Ca-A Cancer Journal for Clinicians, volume 70, issue 1, pages 7-30
Cancer statistics, 2020
1
Surveillance and Health Services ResearchAmerican Cancer Society Atlanta Georgia
|
Publication type: Journal Article
Publication date: 2020-01-08
Journal:
Ca-A Cancer Journal for Clinicians
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 254.7
ISSN: 00079235, 15424863
Oncology
Hematology
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2016) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2017) were collected by the National Center for Health Statistics. In 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States. The cancer death rate rose until 1991, then fell continuously through 2017, resulting in an overall decline of 29% that translates into an estimated 2.9 million fewer cancer deaths than would have occurred if peak rates had persisted. This progress is driven by long-term declines in death rates for the 4 leading cancers (lung, colorectal, breast, prostate); however, over the past decade (2008-2017), reductions slowed for female breast and colorectal cancers, and halted for prostate cancer. In contrast, declines accelerated for lung cancer, from 3% annually during 2008 through 2013 to 5% during 2013 through 2017 in men and from 2% to almost 4% in women, spurring the largest ever single-year drop in overall cancer mortality of 2.2% from 2016 to 2017. Yet lung cancer still caused more deaths in 2017 than breast, prostate, colorectal, and brain cancers combined. Recent mortality declines were also dramatic for melanoma of the skin in the wake of US Food and Drug Administration approval of new therapies for metastatic disease, escalating to 7% annually during 2013 through 2017 from 1% during 2006 through 2010 in men and women aged 50 to 64 years and from 2% to 3% in those aged 20 to 49 years; annual declines of 5% to 6% in individuals aged 65 years and older are particularly striking because rates in this age group were increasing prior to 2013. It is also notable that long-term rapid increases in liver cancer mortality have attenuated in women and stabilized in men. In summary, slowing momentum for some cancers amenable to early detection is juxtaposed with notable gains for other common cancers.
Citations by journals
|
100
200
300
400
500
600
700
800
|
|
|
Frontiers in Oncology
|
Frontiers in Oncology
736 publications, 5.02%
|
|
Cancers
|
Cancers
563 publications, 3.84%
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
233 publications, 1.59%
|
|
BMC Cancer
|
BMC Cancer
172 publications, 1.17%
|
|
Scientific Reports
|
Scientific Reports
169 publications, 1.15%
|
|
Frontiers in Cell and Developmental Biology
|
Frontiers in Cell and Developmental Biology
159 publications, 1.08%
|
|
Frontiers in Genetics
|
Frontiers in Genetics
143 publications, 0.98%
|
|
Frontiers in Immunology
|
Frontiers in Immunology
129 publications, 0.88%
|
|
Cancer Medicine
|
Cancer Medicine
126 publications, 0.86%
|
|
Aging
|
Aging
103 publications, 0.7%
|
|
Medicine (United States)
|
Medicine (United States)
103 publications, 0.7%
|
|
Cell Death and Disease
|
Cell Death and Disease
101 publications, 0.69%
|
|
Cancer Management and Research
|
Cancer Management and Research
98 publications, 0.67%
|
|
Cancer Cell International
|
Cancer Cell International
90 publications, 0.61%
|
|
Gynecologic Oncology
|
Gynecologic Oncology
88 publications, 0.6%
|
|
Annals of Translational Medicine
|
Annals of Translational Medicine
85 publications, 0.58%
|
|
Journal of Oncology
|
Journal of Oncology
76 publications, 0.52%
|
|
Journal of Clinical Medicine
|
Journal of Clinical Medicine
72 publications, 0.49%
|
|
Molecules
|
Molecules
71 publications, 0.48%
|
|
OncoTargets and Therapy
|
OncoTargets and Therapy
69 publications, 0.47%
|
|
Cancer
|
Cancer
66 publications, 0.45%
|
|
Oncogene
|
Oncogene
65 publications, 0.44%
|
|
Biomedicines
|
Biomedicines
64 publications, 0.44%
|
|
Frontiers in Pharmacology
|
Frontiers in Pharmacology
63 publications, 0.43%
|
|
Annals of Surgical Oncology
|
Annals of Surgical Oncology
61 publications, 0.42%
|
|
Diagnostics
|
Diagnostics
59 publications, 0.4%
|
|
Journal of Cancer Research and Clinical Oncology
|
Journal of Cancer Research and Clinical Oncology
58 publications, 0.4%
|
|
Bioengineered
|
Bioengineered
58 publications, 0.4%
|
|
Cells
|
Cells
55 publications, 0.38%
|
|
100
200
300
400
500
600
700
800
|
Citations by publishers
|
500
1000
1500
2000
2500
3000
|
|
|
Springer Nature
|
Springer Nature
2639 publications, 18.01%
|
|
Elsevier
|
Elsevier
2404 publications, 16.4%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
1529 publications, 10.43%
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
1493 publications, 10.19%
|
|
Wiley
|
Wiley
1180 publications, 8.05%
|
|
Wolters Kluwer Health
|
Wolters Kluwer Health
414 publications, 2.82%
|
|
Taylor & Francis
|
Taylor & Francis
413 publications, 2.82%
|
|
AME Publishing Company
|
AME Publishing Company
379 publications, 2.59%
|
|
Dove Medical Press
|
Dove Medical Press
301 publications, 2.05%
|
|
Hindawi Limited
|
Hindawi Limited
285 publications, 1.94%
|
|
SAGE
|
SAGE
236 publications, 1.61%
|
|
American Association for Cancer Research (AACR)
|
American Association for Cancer Research (AACR)
201 publications, 1.37%
|
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
174 publications, 1.19%
|
|
Oxford University Press
|
Oxford University Press
160 publications, 1.09%
|
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
122 publications, 0.83%
|
|
Impact Journals
|
Impact Journals
118 publications, 0.81%
|
|
BMJ
|
BMJ
105 publications, 0.72%
|
|
Future Medicine
|
Future Medicine
103 publications, 0.7%
|
|
Baishideng Publishing Group
|
Baishideng Publishing Group
81 publications, 0.55%
|
|
Spandidos Publications
|
Spandidos Publications
80 publications, 0.55%
|
|
Bentham Science
|
Bentham Science
79 publications, 0.54%
|
|
American Society of Clinical Oncology (ASCO)
|
American Society of Clinical Oncology (ASCO)
72 publications, 0.49%
|
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
63 publications, 0.43%
|
|
Mary Ann Liebert
|
Mary Ann Liebert
59 publications, 0.4%
|
|
Thieme
|
Thieme
40 publications, 0.27%
|
|
Neoplasia Press
|
Neoplasia Press, 38, 0.26%
Neoplasia Press
38 publications, 0.26%
|
|
IOS Press
|
IOS Press
32 publications, 0.22%
|
|
IEEE
|
IEEE
32 publications, 0.22%
|
|
Society for Translational Oncology
|
Society for Translational Oncology
30 publications, 0.2%
|
|
500
1000
1500
2000
2500
3000
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2020,2021,2022,2023,2024],"ids":[0,0,0,0,0],"codes":[0,0,0,0,0],"imageUrls":["","","","",""],"datasets":[{"label":"Citations number","data":[2468,5728,3947,2134,374],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["16.84","39.09","26.93","14.56","2.55"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Frontiers in Oncology","Cancers","International Journal of Molecular Sciences","BMC Cancer","Scientific Reports","Frontiers in Cell and Developmental Biology","Frontiers in Genetics","Frontiers in Immunology","Cancer Medicine","Aging","Medicine (United States)","Cell Death and Disease","Cancer Management and Research","Cancer Cell International","Gynecologic Oncology","Annals of Translational Medicine","Journal of Oncology","Journal of Clinical Medicine","Molecules","OncoTargets and Therapy","Cancer","Oncogene","Biomedicines","Frontiers in Pharmacology","Annals of Surgical Oncology","Diagnostics","Journal of Cancer Research and Clinical Oncology","Bioengineered","Cells"],"ids":[10990,22471,14627,6868,13767,12128,13242,1699,20286,780,19945,25236,17233,9737,16700,25660,10721,26234,1770,3967,16311,20423,24421,9788,2031,18499,552,22749,25293],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/HY0CXgRt044tzIAB16PDvDzdHeKHGtSvlMH0yWf6_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/PYBAYQjpFdxPQPRGY3kU5Xzbu0W7K7umVNk0TY9i_medium.webp","\/storage\/images\/resized\/hqfzhQAjTGlNSRs6yzFNITgjSMm9Jr2QuotJHIvE_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp"],"datasets":[{"label":"","data":[736,563,233,172,169,159,143,129,126,103,103,101,98,90,88,85,76,72,71,69,66,65,64,63,61,59,58,58,55],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[5.02,3.84,1.59,1.17,1.15,1.08,0.98,0.88,0.86,0.7,0.7,0.69,0.67,0.61,0.6,0.58,0.52,0.49,0.48,0.47,0.45,0.44,0.44,0.43,0.42,0.4,0.4,0.4,0.38],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Springer Nature","Elsevier","Multidisciplinary Digital Publishing Institute (MDPI)","Frontiers Media S.A.","Wiley","Wolters Kluwer Health","Taylor & Francis","AME Publishing Company","Dove Medical Press","Hindawi Limited","SAGE","American Association for Cancer Research (AACR)","American Chemical Society (ACS)","Oxford University Press","Royal Society of Chemistry (RSC)","Impact Journals","BMJ","Future Medicine","Baishideng Publishing Group","Spandidos Publications","Bentham Science","American Society of Clinical Oncology (ASCO)","Public Library of Science (PLoS)","Mary Ann Liebert","Thieme","Neoplasia Press","IOS Press","IEEE","Society for Translational Oncology"],"ids":[8,17,202,208,11,32,18,1566,417,6921,31,2286,40,19,123,342,6954,6949,7719,1097,39,73,344,230,135,4513,29,6953,2484],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/PYBAYQjpFdxPQPRGY3kU5Xzbu0W7K7umVNk0TY9i_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/hqfzhQAjTGlNSRs6yzFNITgjSMm9Jr2QuotJHIvE_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/cfuVw6XIq2mATDNJdXiose3W8qYbkmaVSpHoP8XL_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/yNSijlgQghQF53VZuyFLA30CKDe4j3HK74Vtpnxa_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/HY0CXgRt044tzIAB16PDvDzdHeKHGtSvlMH0yWf6_medium.webp","\/storage\/images\/resized\/hysFKdIDQMKHPbF1uLxJ3M6dQA4gPVuC6ZeA7m5a_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/bKOjgSt9mSGUD9fzKZyqcKSIgDCDSMd1ZWjJOZzx_medium.webp","\/storage\/images\/resized\/8zKfOwdd5XirYzTQfqwp7U8IEQc8ckIOjyYQSBkk_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/0WrbuCPHoMon4eqSaqLoeO1owjv6jeDiHASSYzbS_medium.webp","\/storage\/images\/resized\/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_medium.webp","\/storage\/images\/resized\/Zy5YST233rzRbZP24I24MzZm64hz20ZV9qQopmMn_medium.webp","\/storage\/images\/resized\/xqixcltwJYe6H8Uco2JbAFfIOzt7UNKH0OcPOPzO_medium.webp","","\/storage\/images\/resized\/KqWdDIHwzps3KNMz2kSZBC4SgMnkL3bwEKJqtZ2u_medium.webp","\/storage\/images\/resized\/6scCJegesojp2jubwY3uKCzTAmgsaH2GIFlg6Hfk_medium.webp","\/storage\/images\/resized\/sfY8MSm2JdWlg1g91zFkR9FIaCyrBVDo7ouIv6jL_medium.webp"],"datasets":[{"label":"","data":[2639,2404,1529,1493,1180,414,413,379,301,285,236,201,174,160,122,118,105,103,81,80,79,72,63,59,40,38,32,32,30],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[18.01,16.4,10.43,10.19,8.05,2.82,2.82,2.59,2.05,1.94,1.61,1.37,1.19,1.09,0.83,0.81,0.72,0.7,0.55,0.55,0.54,0.49,0.43,0.4,0.27,0.26,0.22,0.22,0.2],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2020 // Ca-A Cancer Journal for Clinicians. 2020. Vol. 70. No. 1. pp. 7-30.
GOST all authors (up to 50)
Copy
Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2020 // Ca-A Cancer Journal for Clinicians. 2020. Vol. 70. No. 1. pp. 7-30.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3322/caac.21590
UR - https://doi.org/10.3322%2Fcaac.21590
TI - Cancer statistics, 2020
T2 - Ca-A Cancer Journal for Clinicians
AU - Siegel, Rebecca L.
AU - Miller, Kimberly D
AU - Jemal, Ahmedin
PY - 2020
DA - 2020/01/08 00:00:00
PB - Wiley
SP - 7-30
IS - 1
VL - 70
SN - 0007-9235
SN - 1542-4863
ER -
Cite this
BibTex
Copy
@article{2020_Siegel,
author = {Rebecca L. Siegel and Kimberly D Miller and Ahmedin Jemal},
title = {Cancer statistics, 2020},
journal = {Ca-A Cancer Journal for Clinicians},
year = {2020},
volume = {70},
publisher = {Wiley},
month = {jan},
url = {https://doi.org/10.3322%2Fcaac.21590},
number = {1},
pages = {7--30},
doi = {10.3322/caac.21590}
}
Cite this
MLA
Copy
Siegel, Rebecca L., et al. “Cancer statistics, 2020.” Ca-A Cancer Journal for Clinicians, vol. 70, no. 1, Jan. 2020, pp. 7-30. https://doi.org/10.3322%2Fcaac.21590.